Bronchiectasis
Key Points
- Bronchiectasis is a chronic lung disorder with widened, damaged bronchi and impaired secretion clearance.
- Retained mucus supports recurrent infection and inflammation, causing progressive airway injury.
- Common manifestations include chronic cough, sputum production, crackles or wheeze, and infection-related symptom flares.
- CT confirms diagnosis; chest x-ray and symptom history alone are not definitive.
- Nursing priorities are infection recognition, oxygenation trend monitoring, airway-clearance support, and trigger reduction.
Pathophysiology
In bronchiectasis, structural damage to the bronchial wall reduces airway elasticity and causes abnormal dilation. These widened airways trap mucus, making expectoration less effective.
Persistent secretion retention increases bacterial burden and drives a recurrent infection-inflammation-damage cycle. Over time, this cycle increases symptom burden and risk of exacerbations.
Classification
- Etiology pattern: Genetic contributors (for example cystic fibrosis or primary ciliary dyskinesia), postinfectious disease, immunosuppression-associated disease, obstruction-associated disease, or idiopathic pattern (about 40 percent).
- Clinical-activity pattern: Baseline chronic cough/sputum with episodic infection-related exacerbations.
- Risk-profile pattern: Higher prevalence in females and older adults; airway obstruction risks include tumor, aspiration, and COPD.
Nursing Assessment
NCLEX Focus
Prioritize active infection signs and oxygenation decline cues before lower-acuity teaching tasks.
- Assess cough and sputum pattern, including daily frequency, volume, color change, and blood presence.
- Monitor for dyspnea, chest tightness, fatigue, chills, fever, night sweats, hemoptysis, and unintentional weight loss.
- Trend vital signs closely; subtle shifts in respiratory rate, SpO2, and temperature can indicate early deterioration.
- Auscultate and map adventitious sounds; crackles are common and wheezes may also occur.
- Screen environmental aggravators: smoking, vaping, secondhand smoke, pollution, dust, and irritant-cleaner exposure.
- Confirm immunization status because preventable respiratory infections can worsen disease burden.
- Recognize diagnostic pattern: persistent cough with sputum most days of the week supports suspicion, then imaging confirms.
- Anticipate diagnostics: chest x-ray for supportive abnormalities, CT for definitive diagnosis, and sputum Gram stain/culture or viral testing when infection is suspected.
- Use spirometry and six-minute-walk data after diagnosis to track trajectory and treatment response rather than to establish diagnosis.
Nursing Interventions
- Escalate fever with purulent sputum, increasing oxygen need, or respiratory distress for provider reassessment.
- Coordinate ordered tests and treatments (for example CT preparation, sputum collection, antipyretics, and antimicrobials).
- Collaborate with respiratory therapy for airway-clearance planning: chest physiotherapy, positive-expiratory-pressure devices, and oscillation vest use.
- Support oxygen therapy goals with team coordination; common inpatient target is often SpO2 above 92 percent unless individualized otherwise.
- If inhaler and nebulizer therapies are both ordered, administer inhaler first to improve downstream medication absorption.
- Treat large-volume hemoptysis as an emergency; prepare for suctioning, airway protection, and bleeding-control procedures.
- Provide teaching on smoking/vaping cessation, environmental-irritant avoidance, and early reporting of infection signs.
- Reassess cough burden, sputum trend, lung sounds, activity tolerance, and oxygen requirement to evaluate response.
Hemoptysis Emergency Risk
Large-volume blood in sputum can rapidly threaten airway patency and requires immediate escalation.
Pharmacology
| Drug Class | Examples | Key Nursing Considerations |
|---|---|---|
| antibiotics | Oral, IV, inhaled, or nebulized regimens | Use pathogen-directed therapy for bacterial infection and monitor symptom/lab response. |
| Antivirals | Influenza/COVID-context regimens | Use when viral infection is identified or strongly suspected. |
| Antifungals plus corticosteroid pathways | Fungal inflammation contexts | Selected fungal-inflammatory etiologies may require both infection and inflammation control. |
| Nebulized hypertonic saline | Airway-secretion thinning therapy | Helps reduce sputum viscosity and supports clearance interventions. |
Clinical Judgment Application
Clinical Scenario
An older adult with known bronchiectasis reports increased purulent sputum, fever, worsening dyspnea, and new blood-streaked sputum.
- Recognize Cues: Infection and oxygenation-risk cues are escalating with possible bleeding risk.
- Analyze Cues: Current status suggests acute exacerbation with high airway-clearance demand.
- Prioritize Hypotheses: Highest priorities are active infection control, oxygenation support, and hemoptysis safety.
- Generate Solutions: Escalate findings, obtain ordered sputum testing/imaging, and intensify airway-clearance and oxygen interventions.
- Take Action: Coordinate interprofessional treatment bundle and monitor response to therapy in short reassessment intervals.
- Evaluate Outcomes: Fever and sputum burden decrease, oxygenation stabilizes, and bleeding does not progress.
Related Concepts
- bronchial-hygiene-techniques - Core secretion-mobilization methods used in bronchiectasis care plans.
- thorax-and-lung-assessment-breath-sounds-and-respiratory-patterns - Supports trend-based recognition of crackles, wheeze, and distress progression.
- sputum-nasal-and-oropharyngeal-specimen-collection - Specimen-quality workflow for infection-directed treatment.
- oxygen-therapy - Oxygen delivery and target reassessment principles during exacerbations.
- cystic-fibrosis - Shared chronic secretion-retention and infection-cycle framework.
Self-Check
- Why is CT required to confirm bronchiectasis even when cough and sputum are persistent?
- Which cues suggest immediate escalation for possible life-threatening complications?
- How do airway-clearance therapies change risk over the long term?